Hospitalization and interventional procedures in cardiology departments covering a region with 2.5 million inhabitants during the SARS-CoV-2 pandemic
Jarosław Dróżdż(Copenhagen University Hospital), Jarosław D. Kasprzak(Medical University of Lodz), Grzegorz Piotrowski(Copernicus Memorial Hospital), Jerzy Krzysztof Wranicz(Medical University of Lodz), Andrzej Lubiński(Medical University of Lodz), Jan Krekora(Medical University of Lodz), Michał Krejca(Medical University of Lodz), Paweł Ptaszyński(Medical University of Lodz), Jarosław Kaźmierczak, Marzenna Zielińska
Cited by 3
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography
|Journal of the American Society of Echocardiography|2011|1.1k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions
|European Journal of Heart Failure|2016|781